Introduction
There is a conversation that too few Nigerian men are having with their doctors, their pharmacists, or even with each other.
It is about the prostate gland a small organ that causes enormous suffering for millions of Nigerian men over the age of 40, yet remains poorly understood and rarely discussed.
Prostate problems affect most men to some degree as they age. In Nigeria, cultural silence, embarrassment, and lack of awareness mean that too many men suffer unnecessarily for years before seeking help.
This guide is designed to change that.
What is the Prostate Gland?
The prostate is a small gland, about the size of a walnut, located just below the bladder and in front of the rectum in men.
It surrounds the urethra the tube that carries urine out of the body.
Its main role is to produce fluid that forms part of semen.
Because of its position, any swelling or inflammation of the prostate directly affects urination. This is why most prostate problems first appear as urinary symptoms.
The Three Main Prostate Conditions
1. Benign Prostatic Hyperplasia (BPH) Enlarged Prostate
BPH is the most common prostate condition.
It is a non-cancerous enlargement of the prostate that becomes more common with age. By age 60, many men will have some degree of enlargement.
BPH is not cancer. Whether it increases the risk of prostate cancer is still debated. Some studies suggest a link, while others show no direct relationship. The association may be due to shared risk factors and increased medical screening rather than a direct cause.
However, BPH can significantly affect quality of life and may lead to:
- Urinary retention
- Bladder damage
- Kidney problems
2. Prostatitis Inflamed Prostate
Prostatitis is inflammation of the prostate, often due to infection.
It can occur at any age and may be:
- Acute (sudden and severe) typically treated with antibiotics for about 2–4 weeks
- Chronic (long-lasting) may require longer treatment, often 4 weeks or more
Symptoms include pain, burning urination, and pelvic discomfort.
With proper treatment, most cases can be managed effectively.
3. Prostate Cancer
Prostate cancer is one of the most common cancers in men worldwide and is more common in men of African descent, including Nigerians.
It often grows slowly, and when detected early, it is highly treatable.
⚠️ In early stages, prostate cancer usually has no symptoms.
This makes screening extremely important.
Symptoms: What to Watch For
Any of the following symptoms should not be ignored:
- Difficulty starting urination
- Weak or interrupted urine stream
- Frequent urination, especially at night
- Feeling of incomplete bladder emptying
- Dribbling after urination
- Sudden urgency to urinate
- Pain or burning during urination
- Blood in urine or semen (urgent attention needed)
- Pain in lower back, hips, or pelvis
- Erectile dysfunction alongside urinary symptoms
⚠️ These symptoms do not always mean cancer but they always require evaluation.
Who is at Risk?
- Age- risk increases significantly after 40
- African descent- higher prostate cancer risk
- Family history- doubles risk
- Diet- high intake of red and processed meat
- Obesity
- Physical inactivity
Diagnosis: How Prostate Problems Are Detected
Digital Rectal Examination (DRE)
A doctor examines the prostate through the rectum.
- Quick
- May feel slightly uncomfortable for some men
- Can detect abnormalities early
It is a simple but important test that can save lives.
PSA Blood Test
The Prostate-Specific Antigen (PSA) test measures a protein in the blood.
- Elevated levels may indicate BPH, infection, or cancer
- Not a definitive cancer test
Men over 40 should discuss PSA testing with their doctor and decide together when to start screening.
Further Tests
If needed:
- Ultrasound
- Biopsy
Treatment Options
For BPH (Enlarged Prostate)
- Watchful waiting (mild cases)
- Alpha-blockers (e.g., tamsulosin)
- 5-alpha reductase inhibitors (e.g., finasteride)
- Surgery (TURP)
For Prostatitis
- Antibiotics (based on cause and duration)
- Anti-inflammatory medications
- Alpha-blockers
⚠️ Always seek professional care avoid self-medication.
For Prostate Cancer
- Active surveillance
- Surgery
- Radiation therapy
- Hormone therapy
- Chemotherapy
How to Protect Your Prostate
- Eat more vegetables (especially cabbage, broccoli, leafy greens)
- Include tomatoes regularly they contain lycopene, which may be associated with a lower risk of prostate cancer, although evidence is still developing
- Reduce red and processed meat
- Maintain a healthy weight
- Exercise regularly
- Stay hydrated
- Limit alcohol
- Get screened regularly
Breaking the Silence
Many Nigerian men suffer in silence.
They ignore symptoms. They avoid doctors. They delay until the problem becomes serious.
With prostate health, this delay can cost lives.
Speaking up early is strength. Screening early saves lives.
Conclusion
Prostate conditions are common, serious, and often highly treatable especially when detected early.
Every Nigerian man over 40 should:
- Know the symptoms
- Understand the risks
- Have regular conversations with a healthcare professional
At Amkamed Pharmaceuticals, Gombe State, our pharmacists are here to guide you on symptoms, medications, and where to access specialist care.
Men over 40: don’t wait. Check your prostate.
Visit Amkamed Pharmaceuticals, Gombe State for guidance and referrals.
References
Prostatic Arterial Embolization for the Treatment of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia.The Cochrane Database of Systematic Reviews. 2022. Jung JH, McCutcheon KA, Borofsky M, et al.
Lower Urinary Tract Symptoms in Men.The Journal of the American Medical Association. 2025. Wei JT, Dauw CA, Brodsky CN.New
Burden and Determinants of Benign Prostate Hyperplasia in Africa: Systematic Review and Meta-Analysis.Cancer Epidemiology. 2025. Seid K, Goshu AT, Lorato SS, et al.New4.Prostate Cancer: A Review.The Journal of the American Medical Association. 2025. Raychaudhuri R, Lin DW, Montgomery RB.
The Role of PSA Screening in Early Detection of Prostate Cancer.American Urological Association (2024). 2023. Guideline
Cancer Statistics for African Americans, 2019.CA: A Cancer Journal for Clinicians. 2019. DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL.
Cancer Statistics for African Americans, 2016: Progress and Opportunities in Reducing Racial Disparities.CA: A Cancer Journal for Clinicians. 2016. DeSantis CE, Siegel RL, Sauer AG, et al.
Prostate Cancer Early Detection.National Comprehensive Cancer Network. Updated 2026-02-18.Guideline
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.The Journal of the American Medical Association. 2018. US Preventive Services Task Force, Grossman DC, Curry SJ, et al.
American Cancer Society Guidelines for the Early Detection of Cancer.American Cancer Society (2023). 2023. Guideline
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.NEJM Evidence. 2024. Garraway IP, Carlsson SV, Nyame YA, et al.
Prostatitis.The Journal of the American Medical Association. 2025. Borgert BJ, Wallen EM, Pham MN.New
Correlation Between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A Systematic Review and Meta-Analysis.Journal of Cancer. 2020. Zhang L, Wang Y, Qin Z, et al.
Association of Clinical Benign Prostate Hyperplasia With Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3,009,258 Men.European Urology. 2011. Ørsted DD, Bojesen SE, Nielsen SF, Nordestgaard BG.
Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results From the Prostate Cancer Prevention Trial.American Journal of Epidemiology. 2011. Schenk JM, Kristal AR, Arnold KB, et al.
Is There Evidence of a Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review.European Urology. 2009. Alcaraz A, Hammerer P, Tubaro A, Schröder FH, Castro R.
The Link Between Benign Prostatic Hyperplasia and Prostate Cancer.Nature Reviews. Urology. 2013. Ørsted DD, Bojesen SE.
How I Manage Bacterial Prostatitis.Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2023. Lam JC, Lang R, Stokes W.
Effect of Carotene and Lycopene on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies.PloS One. 2015. Wang Y, Cui R, Xiao Y, Fang J, Xu Q.
A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk.Journal of the National Cancer Institute. 2002. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC.
Tomato Consumption and Intake of Lycopene as Predictors of the Incidence of Prostate Cancer: The Adventist Health Study-2.Cancer Causes & Control : CCC. 2020. Fraser GE, Jacobsen BK, Knutsen SF, Mashchak A, Lloren JI.
Dietary Lycopene, Angiogenesis, and Prostate Cancer: A Prospective Study in the Prostate-Specific Antigen Era.Journal of the National Cancer Institute. 2014. Zu K, Mucci L, Rosner BA, et al.
Tomatoes, Lycopene, and Prostate Cancer: What Have We Learned From Experimental Models?.The Journal of Nutrition. 2022. Moran NE, Thomas-Ahner JM, Wan L, et al.
Tomato and Lycopene and Multiple Health Outcomes: Umbrella Review.Food Chemistry. 2021. Li N, Wu X, Zhuang W, et al.
A Review of Epidemiologic Studies of Tomatoes, Lycopene, and Prostate Cancer.Experimental Biology and Medicine. 2002. Giovannucci E.